Categories: Share Market

Valiant Laboratories IPO Day 3: Check GMP Today, Subscription Status

Reported By: Mohammad Haris

Last Updated: September 29, 2023, 08:10 IST

Valiant Laboratories IPO: GMP, Price, Subscription, all you need to know.

Unlisted shares of Valiant Laboratories Ltd remain Rs 17 higher in the grey market as compared to its issue price

Valiant Laboratories IPO: The initial public offering (IPO) of pharmaceutical ingredient manufacturing firm Valiant Laboratories, which will conclude today, Friday, September 29, was subscribed 71 per cent on the second day of bidding on Thursday. The Rs 152.46-crore IPO received bids for 54,25,770 shares against 76,23,030 units on offer.

The category for retail individual investors (RIIs) was subscribed 1.27 times, while the quota for non-institutional investors received 29 per cent subscription. The portion for qualified institutional buyers (QIBs) was subscribed 5 per cent.

Valiant Laboratories IPO GMP Today

According to market observers, unlisted shares of Valiant Laboratories Ltd remain Rs 17 higher in the grey market as compared to its issue price. The Rs 17 grey market premium or GMP is about 12.14 per cent higher than its upper issue price of Rs 140 per share. This means the grey market is expecting a 12.14 per cent listing gain from the public issue.

‘Grey market premium’ indicates investors’ readiness to pay more than the issue price.

Valiant Laboratories IPO Details

The IPO was opened for public subscription on September 27, and will conclude today. It is an entirely fresh issuance of up to 1.08 crore equity shares with no offer-for-sale component.

The price range for the offer is Rs 133-140 a share. Investors can bid for a minimum of 69 shares and in multiples thereof.

The proceeds of the issue will be utilised to set up a manufacturing facility for speciality chemicals in Gujarat through its subsidiary — Valiant Advanced Sciences Private Ltd. — and to meet the working capital requirements of the subsidiary company.

Valiant Laboratories is an active pharmaceutical ingredient or bulk drug manufacturing company with its focus on manufacturing paracetamol, used in the treatment of headaches, muscle aches, arthritis, backache, toothache, cold and fever.

Unistone Capital is the manager to the offer.

Equity shares of the company will be listed on the BSE and the NSE.

Source link

jaghit

Share
Published by
jaghit

Recent Posts

'मुख्यमंत्री कोविड-19 बाल सेवा योजना' के लिए नहीं है बजट? अब मंत्री नरेंद्र पटेल ने किया ये दावा

<p style="text-align: justify;"><strong>Madhya Pradesh News Today:</strong> भारत सहित पूरी दुनिया ने 3 साल वैश्विक महामारी…

3 months ago

Inside Hina Khan’s Pre-Birthday Celebrations With Rocky Jaiswal And Mother In Goa

Hina Khan’s birthday is on October 2. (Photo Credits: Instagram)From a stunning view of her…

3 months ago

Swiggy IPO Gets Sebi Approval: All You Need to Know About Rs 11,000-Crore Issue

Food and grocery delivery major Swiggy has received markets regulator Sebi’s clearance to launch its…

3 months ago

‘Imprints of Make in India visible everywhere’: PM Modi lauds 10 years of flagship initiative | India News

NEW DELHI: Prime Minister Narendra Modi on Wednesday lauded the efforts of each and every…

3 months ago

Waqf Amendment Bill JPC 1 Crore Emails Nishikant Dubey VHP Vinod Bansal Said it Email Jihad | वक्फ बिल पर 1 करोड़ से ज्यादा सुझाव: VHP बोली

Waqf Amendment Bill Email: वक्फ संशोधन बिल पर संयुक्त संसदीय समिति (जेपीसी) को सुझाव के लिए…

3 months ago

Georgia Meloni and Elon Musk date truth behind the viral photos

Meloni And Musk Viral Photos : दुनिया के सबसे अमीर शख्स एलन मस्क ज्यादातर किसी…

3 months ago